A carregar...
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma
Drug resistance remains the key problem in cancer treatment. It is now accepted that each myeloma patient harbors multiple subclones and subclone dominance may change over time. The coexistence of multiple subclones with high or low chromosomal instability (CIN) signature causes heterogeneity and dr...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6026005/ https://ncbi.nlm.nih.gov/pubmed/29863498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI98765 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|